Kanya Rajangam
CIK 1816676 · Pres. & Chief Med. & Dev. Off. · last filed 2026-03-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$140.2K
Companies
3
Total Filings
15
Lifetime Open-Market Net
-$378.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SNTI | Pres. & Chief Med. & Dev. Off. | 107,843 | $0.96 | $103.6K | -$6.1K | 9 | 2026-03-11 |
| Turnstone Biologics Corp. (TSBX) Delisted | Director | — | $0.35 | — | $0 | 2 | 2024-07-02 |
| NKTX | Chief Medical Officer | 12,800 | $2.86 | $36.6K | -$372.8K | 4 | 2022-01-19 |
Recent Filings · Page 2 of 2
15 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-07-20 | SNTI | Grant (A) | — | $0 | EDGAR |
| 2022-01-19 | NKTX | Grant (A) | +12,800 | $0 | EDGAR |
| 2021-08-09 | NKTX | Mixed | — | -$368.7K | EDGAR |
| 2021-01-12 | NKTX | Grant (A) | — | $0 | EDGAR |
| 2020-07-13 | NKTX | Grant (A) | — | $0 | EDGAR |
Showing 11–15 of 15
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.